Design of Dimeric Bile Acid Derivatives as Potent and Selective Human NTCP Inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design of Dimeric Bile Acid Derivatives as Potent and Selective Human NTCP Inhibitors
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 9, Pages 5973-6007
Publisher
American Chemical Society (ACS)
Online
2021-04-28
DOI
10.1021/acs.jmedchem.1c00078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
- (2017) Satomi Shimura et al. JOURNAL OF HEPATOLOGY
- Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection
- (2017) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus
- (2016) Yonghe Qi et al. PLoS Pathogens
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
- (2015) Manabu Kaneko et al. JOURNAL OF VIROLOGY
- Hydrophobicity Is the Governing Factor in the Interaction of Human Serum Albumin with Bile Salts
- (2015) Narayani Ghosh et al. LANGMUIR
- Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide
- (2015) Kaori Okuyama-Dobashi et al. Scientific Reports
- Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
- (2015) Wenhui He et al. PLoS Pathogens
- Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
- (2014) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes
- (2014) Alexander König et al. JOURNAL OF HEPATOLOGY
- Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide
- (2014) H. Yan et al. JOURNAL OF VIROLOGY
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
- (2013) Koichi Watashi et al. HEPATOLOGY
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide
- (2013) H. Yan et al. JOURNAL OF VIROLOGY
- Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
- (2012) Julie Lucifora et al. ANTIVIRAL RESEARCH
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started